Medi Assist Healthcare logo

Medi Assist Healthcare

MEDIASSIST NSE

Key Fundamentals

MicrocapInsurance DistributionInsurance
Market Cap
₹2,346 Cr
Volatility
Moderate
P/E Ratio
25.19
EBITDA
₹160 Cr
Return on Equity
16.59%
Debt to Equity
0.06
Book Value
₹112.31
EPS
₹12.98
52W High
₹575.55
52W Low
₹293

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has reduced debt.
  • Company is almost debt free.

Weaknesses

3
  • Promoter holding is low: 4.61%
  • Tax rate seems low
  • Dividend payout has been low at 14.4% of profits over last 3 years

Growth Rate

Revenue Growth
21.1% higher than 3Y
Net Income Growth
-48.48% lower than 3Y
Cash Flow Change
108% higher than 3Y
ROE
12.02% lower than 3Y
ROCE
13.29% higher than 3Y
EBITDA Margin (Avg.)
-27.05% lower than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 69d ago
AI opinion · based on fundamentals
Risk medium

Medi Assist Healthcare Services is a health insurance TPA/insurtech platform with a market cap of ~₹2,780 crore, trading at a PE of 31.3x. The company delivered FY26 consolidated revenue of ₹905 crore (25% YoY growth) with a 5-year sales CAGR of 23%, though PAT dipped marginally to ₹89 crore in FY26 from ₹92 crore in FY25 and the stock has declined 29% over the past year.

Bull Case 8
  • Strong revenue growth trajectory — FY26 consolidated sales of ₹905 crore, up 25% YoY from ₹723 crore in FY25, with a 5-year compounded sales CAGR of 23%
  • Premium under management reached ₹15,829 crore as of Dec 2024, up 16.6% YoY, providing visibility on future revenue streams
  • Retail premium segment growing at 31.2% YoY (₹2,050 crore), faster than overall group premium growth of 14.7%, indicating diversification
  • Company is almost debt-free with reduced leverage, lowering financial risk and interest burden
  • High group account retention rate of 94.3%, demonstrating client stickiness and recurring revenue characteristics
  • 5-year compounded profit CAGR of 32%, reflecting operating leverage as the business scales
  • Operating EBITDA margin maintained above 19-21% range (FY26 OPM at 18.9%, FY25 at 20.6%), indicating platform scalability
  • Dividend yield of 1.07% with a 17% payout in FY26, signalling improving shareholder returns from a near-zero payout in FY25
Bear Case 8
  • Stock has declined 29% over the past year, significantly underperforming the broader market and eroding investor wealth
  • Promoter holding is extremely low at just 4.61%, raising governance and alignment concerns for minority shareholders
  • FY26 PAT declined to ₹89 crore from ₹92 crore in FY25 despite 25% revenue growth, with OPM compressing from 20.6% to 18.9%
  • TTM profit growth of only 9% versus 25% revenue growth indicates margin pressure and rising costs (depreciation up from ₹56 crore to ₹77 crore in FY26)
  • PE of 31.3x is elevated for a company with single-digit near-term profit growth, implying high expectations are priced in
  • ROE has trended down from 17% (5-year average) to 14% in the last year, suggesting declining capital efficiency
  • Interest costs more than doubled from ₹10.3 crore in FY25 to ₹21.4 crore in FY26, potentially linked to acquisitions or working capital needs
  • Low 3-year average dividend payout of 14.4% of profits, with inconsistent payout history (0% in FY25, 42% in FY24), limiting income-oriented appeal

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 69d ago
Positives 1
  • Raising stake in UK unit Jun 24

    Medi Assist to acquire 31.75% additional shares in Mayfair We Care Limited for GBP 589,270, increasing holding from 60% to 91.75%, strengthening control over its UK subsidiary.

TL;DR: Medi Assist is consolidating ownership of its UK subsidiary Mayfair We Care, signaling confidence in international operations. No negative developments reported in this period. The move toward near-full ownership of the UK unit could unlock operational synergies, though the investment size is modest. Trend appears stable with a slight international expansion tilt.

Quarterly Results

Particulars Mar 2023Jun 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
136
141
166
167
168
181
186
189
191
233
240
242
237
Expenses
105
118
132
130
132
142
146
148
149
193
195
194
189
Operating Profit
31
22
34
37
35
38
40
41
42
40
45
48
48
OPM %
23%
16%
20%
22%
21%
21%
21%
22%
22%
17%
19%
20%
20%
Other Income
2
5
4
4
5
6
4
8
7
2
-7
3
10
Interest
1
1
1
1
2
2
2
4
5
8
8
2
2
Depreciation
8
8
11
12
14
14
14
14
14
21
21
21
22
PBT
23
18
26
28
25
30
27
30
31
13
8
28
35
Tax %
32%
3%
17%
9%
24%
29%
-10%
28%
26%
40%
51%
-95%
21%
Net Profit
16
18
21
26
19
21
30
22
23
8
4
54
28
EPS in Rs
2.3
2.58
2.98
3.58
2.68
2.99
4.19
3.05
3.18
1.13
0.56
7.16
3.71
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
277
319
323
394
505
635
723
905
951
Expenses
194
237
247
302
385
501
569
730
770
Operating Profit
82
82
76
92
120
133
154
175
181
OPM %
30%
26%
23%
23%
24%
21%
21%
19%
19%
Other Income
-14
7
11
21
12
-5
24
5
9
Interest
4
4
6
3
3
3
10
23
20
Depreciation
23
27
32
28
27
43
56
77
85
PBT
41
59
49
81
102
82
112
80
85
Tax %
37%
41%
47%
21%
28%
16%
18%
-11%
—
Net Profit
26
35
26
64
74
69
92
89
94
EPS in Rs
7,255
9,576
7,065
9.33
10.76
9.53
12.89
11.78
12.56
Div. Payout %
0%
0%
0%
20%
18%
26%
0%
17%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.04
0.04
0.04
34
34
35
35
37
Reserves
218
212
290
303
342
437
506
802
Borrowings
98
115
35
27
31
26
204
54
Other Liabilities
202
231
220
238
295
344
412
479
Total Liabilities
518
558
545
602
702
842
1,158
1,372
Fixed Assets
142
138
119
99
171
246
306
659
CWIP
3
1
1
6
0
3
4
0
Investments
88
72
111
201
44
77
274
158
Other Assets
285
347
315
296
487
516
574
556
Total Assets
518
558
545
602
702
842
1,158
1,372
Figures in ₹ Crores

Cash Flow

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
35
19
139
64
81
66
138
118
Investing
-21
-22
-61
-83
-10
-55
-218
-160
Financing
-10
-12
-10
-30
-32
-15
112
12
Net Cash Flow
4
-15
69
-49
39
-3
32
-30
Free Cash Flow
14
-2
126
62
53
49
92
62
CFO/OP
97
70
141
116
100
70
89
68
Figures in ₹ Crores

Ratios

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
119
78
137
110
92
103
112
116
Cash Conversion Cycle
119
78
137
110
92
103
112
116
Working Capital Days
-80
-103
-73
-59
-66
-43
-105
25
ROCE %
—
20%
19%
23%
26%
23%
19%
14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Medi Assist Healthcare insights

57 extracted metrics + investor summaries across FY19–FY26.

Log in — free

Shareholding Pattern

Promot.4.61%DIIs47.24%Others7.78%Public14.96%FIIs25.42%As ofJun 2026

Documents

Frequently Asked Questions about Medi Assist Healthcare

What does Medi Assist Healthcare Services Ltd do?
Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.[1]
Where is Medi Assist Healthcare Services Ltd (MEDIASSIST) listed?
Medi Assist Healthcare Services Ltd trades as MEDIASSIST on the NSE and under code 544088 on the BSE.
Which sector does Medi Assist Healthcare Services Ltd belong to?
Medi Assist Healthcare Services Ltd is classified under the Insurance sector, in the Insurance Distribution industry.
What is the market capitalisation of Medi Assist Healthcare Services Ltd?
Medi Assist Healthcare Services Ltd has a market capitalisation of ₹2,346 Cr, which places it in the Small Cap band.
What is the PE ratio of Medi Assist Healthcare Services Ltd?
Medi Assist Healthcare Services Ltd trades at a PE ratio of 25.19, on earnings per share of ₹12.98, against a book value of ₹112.31 per share.
What is the 52-week high and low of Medi Assist Healthcare Services Ltd?
Over the last 52 weeks Medi Assist Healthcare Services Ltd has traded between ₹293 and ₹575.55.
Does Medi Assist Healthcare Services Ltd pay dividends?
Medi Assist Healthcare Services Ltd has a dividend yield of 0.62%.
What is the Return on Equity (ROE) of Medi Assist Healthcare Services Ltd?
Medi Assist Healthcare Services Ltd reported a return on equity of 16.59%. Its debt-to-equity ratio is 0.06.

Company Information

Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.[1]

Website mediassist.in
Listed 2024-01-23
Face Value ₹ 5
Issued Size 7,44,57,742

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MEDIASSIST.md for Medi Assist Healthcare Services Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Insurance → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List